Kymera Therapeutics's total assets for Q1 2025 were $918.31M, a decrease of -6.11% from the previous quarter. KYMR total liabilities were $132.08M for the fiscal quarter, a -7.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.